KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Johnson & Johnson (JNJ) EBITDA Margin (2016 - 2026)

Johnson & Johnson's EBITDA Margin history spans 18 years, with the latest figure at 26.44% for Q1 2026.

  • On a quarterly basis, EBITDA Margin fell 179.0% to 26.44% in Q1 2026 year-over-year; TTM through Mar 2026 was 41.62%, a 1779.0% increase, with the full-year FY2025 number at 42.39%, up 1873.0% from a year prior.
  • EBITDA Margin hit 26.44% in Q1 2026 for Johnson & Johnson, down from 81.68% in the prior quarter.
  • Over the last five years, EBITDA Margin for JNJ hit a ceiling of 88.12% in Q4 2023 and a floor of 15.98% in Q4 2024.
  • Historically, EBITDA Margin has averaged 33.75% across 5 years, with a median of 27.36% in 2023.
  • Biggest five-year swings in EBITDA Margin: crashed -7214bps in 2024 and later surged 6570bps in 2025.
  • Tracing JNJ's EBITDA Margin over 5 years: stood at 26.5% in 2022, then skyrocketed by 233bps to 88.12% in 2023, then tumbled by -82bps to 15.98% in 2024, then soared by 411bps to 81.68% in 2025, then plummeted by -68bps to 26.44% in 2026.
  • Business Quant data shows EBITDA Margin for JNJ at 26.44% in Q1 2026, 81.68% in Q4 2025, and 29.31% in Q3 2025.